Contrafect Corp (CFRX)

[Gains2000]

Interesting observation for what its worth from Clinicaltrials website:

The Phase 3 DISRUPT trial of Exebacase has 41 open trial Sites enrolling (Hospitals) in the U.S. currently. In the Phase 2 trial of Exebacase, there were 78 sites throughout the world of which 31 were in the U.S.

I realize that DISRUPT trial design involves only U.S. sites and there is a distinct advantage of this I e uniform standard of care. I just like that they have more sites open in the US which bodes well for enrollment to accelerate.

Having said this, management's silence likely means things are going slower cause of the pandemic. Hoping for some new guidance soon.